Related Experiment Video
Updated: Oct 17, 2025
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.9K
Stroke prevention in atrial fibrillation.
Gregory Y H Lip1, Ying Gue2, Juqian Zhang2
1Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Trends in Cardiovascular Medicine
|October 7, 2021
Summary
Atrial fibrillation (AF) stroke prevention is best managed with non-vitamin K antagonist oral anticoagulants. Integrated care pathways, like the ABC (Atrial fibrillation Better Care) pathway, improve patient outcomes by focusing on stroke avoidance, symptom management, and cardiovascular risk optimization.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a common heart rhythm disorder significantly increasing stroke risk.
- Oral anticoagulants are crucial for preventing stroke in AF patients.
- Recent advancements in AF management focus on stroke prevention and integrated care.
Purpose of the Study:
- To review recent advances (2015-2020) in treating and preventing stroke in atrial fibrillation.
- To summarize updates in international guidelines for AF management.
Main Methods:
- Comprehensive literature search of MEDLINE publications from March 2015 to December 2020.
- Focused on primary research articles and systematic reviews.
- Included updates from international guidelines.
Main Results:
- Improved AF detection and risk stratification are key for identifying patients needing anticoagulation.
- Non-vitamin K antagonist oral anticoagulants are recommended over warfarin for efficacy and safety.
- Integrated care models, including the ABC pathway, improve AF patient outcomes beyond stroke prevention.
Conclusions:
- Stroke prevention remains central to AF management, with anticoagulation recommended for most patients.
- Risk assessment should be dynamic, considering individual factors beyond simple risk scores.
- Holistic care, encompassing stroke prevention, symptom control, and comorbidity management (ABC pathway), is essential for optimal AF patient outcomes.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
60
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
01:26Coronary Artery Disease IV: Preventive Measures
397
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
397
01:25Dysrhythmias VI: Management of Dysrhythmias
163
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
163
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
01:29Disturbances in Heart Rhythm
1.6K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.6K